|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1998-2-11
|
|
pubmed:abstractText |
Tacrolimus has been shown to have a less adverse effect on the lipid profiles of transplant patients when the drug is started as induction therapy. In order to determine the effect tacrolimus has on lipid profiles in stable cyclosporine-treated renal transplant patients with established hyperlipidemia, a randomized prospective study was undertaken by the Southeastern Organ Procurement Foundation.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Blood Glucose,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, HDL,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, LDL,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, VLDL,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclosporine,
http://linkedlifedata.com/resource/pubmed/chemical/Hemoglobin A, Glycosylated,
http://linkedlifedata.com/resource/pubmed/chemical/Immunosuppressive Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Lipids,
http://linkedlifedata.com/resource/pubmed/chemical/Tacrolimus,
http://linkedlifedata.com/resource/pubmed/chemical/Triglycerides
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0041-1337
|
|
pubmed:author |
pubmed-author:AdamsP APA,
pubmed-author:ArmataTT,
pubmed-author:BlantonJJ,
pubmed-author:BurdickJ FJF,
pubmed-author:GaberA OAO,
pubmed-author:HayesJ MJM,
pubmed-author:JonssonJJ,
pubmed-author:LipisS MSM,
pubmed-author:McCuneT RTR,
pubmed-author:MulloyLL,
pubmed-author:PetersT GTG,
pubmed-author:PruettTT,
pubmed-author:RohrM SMS,
pubmed-author:SelmanS HSH,
pubmed-author:Thacker LRI III,
pubmed-author:WrightF HFHJr,
pubmed-author:YiumJJ
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
65
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
87-92
|
|
pubmed:dateRevised |
2010-3-24
|
|
pubmed:meshHeading |
pubmed-meshheading:9448150-Adult,
pubmed-meshheading:9448150-Blood Glucose,
pubmed-meshheading:9448150-Cholesterol, HDL,
pubmed-meshheading:9448150-Cholesterol, LDL,
pubmed-meshheading:9448150-Cholesterol, VLDL,
pubmed-meshheading:9448150-Cyclosporine,
pubmed-meshheading:9448150-Female,
pubmed-meshheading:9448150-Hemoglobin A, Glycosylated,
pubmed-meshheading:9448150-Humans,
pubmed-meshheading:9448150-Hyperlipidemias,
pubmed-meshheading:9448150-Immunosuppressive Agents,
pubmed-meshheading:9448150-Kidney Transplantation,
pubmed-meshheading:9448150-Lipids,
pubmed-meshheading:9448150-Male,
pubmed-meshheading:9448150-Middle Aged,
pubmed-meshheading:9448150-Postoperative Complications,
pubmed-meshheading:9448150-Tacrolimus,
pubmed-meshheading:9448150-Triglycerides
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Effects of tacrolimus on hyperlipidemia after successful renal transplantation: a Southeastern Organ Procurement Foundation multicenter clinical study.
|
|
pubmed:affiliation |
Nephrology Associates of Tidewater Sentara Norfolk General Hospital, Virginia, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
